Buchynskyi, M.; Kamyshna, I.; Halabitska, I.; Petakh, P.; Oksenych, V.; Kamyshnyi, O.
Genetic Predictors of Paxlovid Treatment Response: The Role of IFNAR2, OAS1, OAS3, and ACE2 in COVID-19 Clinical Course. J. Pers. Med. 2025, 15, 156.
https://doi.org/10.3390/jpm15040156
AMA Style
Buchynskyi M, Kamyshna I, Halabitska I, Petakh P, Oksenych V, Kamyshnyi O.
Genetic Predictors of Paxlovid Treatment Response: The Role of IFNAR2, OAS1, OAS3, and ACE2 in COVID-19 Clinical Course. Journal of Personalized Medicine. 2025; 15(4):156.
https://doi.org/10.3390/jpm15040156
Chicago/Turabian Style
Buchynskyi, Mykhailo, Iryna Kamyshna, Iryna Halabitska, Pavlo Petakh, Valentyn Oksenych, and Oleksandr Kamyshnyi.
2025. "Genetic Predictors of Paxlovid Treatment Response: The Role of IFNAR2, OAS1, OAS3, and ACE2 in COVID-19 Clinical Course" Journal of Personalized Medicine 15, no. 4: 156.
https://doi.org/10.3390/jpm15040156
APA Style
Buchynskyi, M., Kamyshna, I., Halabitska, I., Petakh, P., Oksenych, V., & Kamyshnyi, O.
(2025). Genetic Predictors of Paxlovid Treatment Response: The Role of IFNAR2, OAS1, OAS3, and ACE2 in COVID-19 Clinical Course. Journal of Personalized Medicine, 15(4), 156.
https://doi.org/10.3390/jpm15040156
